Is Necitumumab An Effective Antibody Against EGFR for Patients with Squamous Lung Cancer?

Dr. Nasser Hanna discusses the SQUIRE trial of the EGFR antibody Necitumumab in patients with squamous lung cancer. Though it achieved a statistical increase in OS, he does not consider it clinically relevant.